Galena Biopharma Inc (NASDAQ:GALE)
| 2.50 Data as of May 21 |  +0.035 / +1.42%Today’s Change | 1.17 Today|||52-Week Range 3.00 | +63.40% Year-to-Date |
Latest GALE News | Press Releases
No recent news for Galena Biopharma Inc.
Today’s Trading
| Previous close | 2.47 |
| Today’s open | 2.50 |
| Day’s range | 2.44 - 2.54 |
| Volume | 1,468,281 |
| Average volume (3 months) | 2,036,722 |
| Market cap | $205.7M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -75.00% |
| Earnings growth (this year) | +29.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PGNXProgenics Pharmaceut... | -0.15 | -3.60% |
| VNDAVanda Pharmaceutical... | +0.15 | +2.16% |
| CTIXCellceutix Corp | -0.03 | -1.47% |
| --Genufood Energy Enzy... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$35.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Mark J. Ahn, PhD, MBA |
Chief Operating Officer & Executive Vice President Mark W. Schwartz, PhD |
Corporate headquarters Lake Oswego, Oregon |
Forecasts
